A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a)

16517AMGEN-20230222OpenA Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a)NCT07136012IndustrialAdultTreatmentOtherPark, JeanMedStar Health and GUMC; Medstar Montgomery Medical CenterMHRI Community Research17019Mehrnoosh EmamiMehrnoosh Emamimehrnoosh.emami@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>